Vitruvius Biosciences is a biotechnology company developing products addressing current and imminent needs in the applied genomics, proteomics, and molecular diagnostics fields. The rapid growth in these fields is driven by extremely attractive economic predictions and scenarios involving primarily the assimilation and processing of large amounts of genetic (DNA and RNA) or proteomic (protein) data in order to: 1. Identify new pharmaceutical target strategies 2. Provide personalized medicines based upon an individualâs genetic background 3. Provide safer medicines by identifying toxicological parameters influenced by genetics 4. Implement preventative medicine approaches based upon genetic predisposition to disease 5. Expand diagnostic capabilities for human, veterinary, agricultural, and environmental diseases and pathogens, including those associated with bioterrorism. 6. Provide insights into complex biological system
